Select Page

Dr. Benedict Albensi, Principal Investigator, Synaptic Plasticity and Cellular Memory Dysfunction Lab, Division of Neurodegenerative Disorders, has been accepted to the Canadian Consortium on Neurodegeneration in Aging (CCNA).

The CCNA provides the infrastructure and support that facilitates collaboration amongst Canada’s top dementia researchers. By accelerating the discovery, innovation, and the adoption of new knowledge, the CCNA positions Canada as a global leader in increasing understanding of neurodegenerative diseases, working towards prevention, and improving the quality of life of those living with dementia.

Dr. Albensi is a Professor of Pharmacology & Therapeutics at the University of Manitoba, holds the Manitoba Dementia Research Chair (MDRC), and the Everett Endowment Fund Chair.